Premium
Perceptions of Self and Short Stature: Effects of Two Years of Growth Hormone Treatment
Author(s) -
BOULTON T.J.C.,
DUNN S.M.,
QUIGLEY C.A.,
TAYLOR J.J.,
THOMPSON L.
Publication year - 1991
Publication title -
acta paediatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/apa.1991.80.s377.20
Subject(s) - medicine , short stature , confidence interval , bone age , cohort , demography , pediatrics , tall stature , growth hormone deficiency , growth hormone , population , el niño , hormone , environmental health , sociology
A cohort study was carried out to determine whether childrens' perception of the problem of short stature changed over 2 years of growth hormone (GH) therapy. A total of 66 children (age range, 5–15 years; mean 10.2 years) were selected on the basis of height below the 3rd centile for chronological age, height velocity below the 25th centile for bone age, prepubertal status, and absence of any organic condition causing growth failure or likely to interfere with GH action. The children were taking part in a 2‐year multicentre trial to assess the effect of authentic recombinant GH on short, slowly growing children without Gil deficiency (GHD). The childrens' and parents' attitudes and emotional adjustment to shortness were assessed before GH therapy commenced, and at 6 months and 2 years, using a growth‐specific psychological instrument, the Attitude to Growth scale (ATG). The children were also assessed using the Piers Harris Children Self Concept Scale at 2 years. The mean ATG scores increased from 34.2 (95% confidence interval, 33.2–35.2) at intake to 37.2 (95% confidence interval, 36.2–38.2) at 2 years. Younger subjects had a greater increase ( p < 0.05). No sex differences occurred. Two separate factors were identified in the childrens' attitudes: emotional preoccupation with stature and a concrete focus on practical aspects. No differences were present between childrens' and parents' mean scores, though parents' estimates differed on selected items. The mean Piers Harris score at 2 years was within the normal range, and was positively correlated to the ATG but was unrelated to height. It is concluded that GH treatment may have a beneficial effect on childrens' attitudes to being short, particularly in the younger child. It is recommended that parents undergo careful evaluation before their children are offered long‐term treatment with GH, so that their understanding of their child's perceptions is clarified, and their own hopes and expectations of treatment become realistic and supportive to the child.